SPX/MKT note / FXI observations coming into next week 8.18.19

So sure, I’m constructive on the MKT to the extent that I don’t think we’re going into a bear MKT- and I DO think the “Daily” trend is likely to stay intact above 2820-40- on a closing basis.

I DO think, however- we will likely “churn” a bit within this trading range we have established between 2950-2840- this week into 8.23.19 when bigger signals start to fire and the TIME signal schematic begins to improve.

I’m hoping that we can maintain the current trend structure within the range highlighted above(2840-2950)-

We need to get through Tues-Thurs…

*I’m worried about FXI MKT– this week…This thing looks like its set up to move aggressively lower-  BUT, I thought that in late June and it never happened…

Here is the weekly chart- does NOT look good and we have SELL signals in weekly’s and dailies coming in this week…

Adam Lorraine-

 

The process of listing on NYSC or NASDAQ is a serious undertaking

Nasdaq has a fiduciary obligation to its traded companies and all those shareholders. The process of listing on NYSC or NASDAQ is a serious undertaking. 

While I appreciate your pain and frustration, NASDAQ has to get it right, and must complete their internal review of any applicant submission (Form 10), and gather any and all information necessary to comply with the listing regulations, not to mention FINRA and SEC laws and disclosures. 

Surely NASDAQ has requested clarification (it is mandated in the listing due-diligence process, which is linked below) to review and gather responses from Predictive and other sources to the Hindenburg report. What I did learn is Hindenburg is known to NASDAQ and not in a favorable or positive light. 

My insight tells me that review is near completion but certainly no NASDAQ official would have been allowed to reveal those details, in fact, the compliance team can not meet with Predictive but other officials can and have. Those meetings were not negative is all I can say. 

One logical observation, why would Bradly Robinson take a company, alleged to be ripe with misrepresentations and bad deeds, to become listed on a much stricter exchange? Why go through the millions of dollars and months and months of human resources, assemble a world-class Board and management team, invest days and nights over 15 months of hard work, all to file false and misleading statements (BTW statements that are audited and reviewed by law firm after law firm, auditors, and highly reputable wall street firms) with the aim to try and get away with a fabrication? It’s not logical. Do you know why? Because none of the allegations are accurate but for the manipulation of the market and profit. 

That’s my take for the moment, hope it helps you to hold and continue to be a shareholder.   

Endorsement

Whenever I invest in a company I look at the fundamentals but also like to see where the rubber meets the road.This morning at 10 am I had an appointment with with a quality Medical group using Predictives Corecyte.I have a sports hernia and have seen many doctors,chiropractors etc over the past four years with no relief, cortisone injections,PT, alternative medicine with no relief- so I decided that I am going to try PRED’s product first hand to see if it really works. I asked the nurse and practitioners some questions this morning: 

1. How long have you been using PRED’s Corecyte: For about 1 year and we found it far superior to the product we were using Amniotech for the past 4 years- we have had great results with Corecyte about 95% satisfaction of our patients. She said the key factor is PRED’s product is far superior with 1.1 Million live mesenchymal stem cells per ml-a much higher concentration than Amniotech.A higher concentration of stem cells reduces patients costs and administering multiple times- and real key much more effective. They also mentioned the professionalism of the company – they keep a live nitrogen freezer at there site. They have treated backs,necks,knees, shoulders with excellent results. Next week I have a follow up meeting so I will probably get my first injection- so I will keep everyone posted as I have thousands of reasons why. First impression where rubber meets the road : A ++ on quality of product and efficacy-company professionalism. 

Your Jump On The Week

A Breakdown of the Week That Was, And What’s Ahead

 

Aug. 10, 2019

 

Hello trader,


When it was all said and done this week, here are what the final numbers looked like: Dow (-0.7%), S&P 500 (-0.5%), Nasdaq (-0.6%). 


And while all major indices posted a modest decline, those numbers don’t tell us how wacky and wild it was for traders. 


We can thank the ongoing trade war between the U.S. and China for adding to this week’s market volatility.  


Here are some highlights:

 

  • Dow drops as much as 925 points on Monday amid increased trade talk tensions between the U.S. and China, while the Nasdaq drops by more than 3.4% on the day

  • Stocks catch a bounce on Tuesday, gaining a little more than 1% and snapping a six-day losing streak

  • On Wednesday the Dow nearly drops 600 points only to recover and close almost unchanged. In what was the biggest red to green intraday swing we’ve seen all year. 

  • China devalued its currency against the U.S. dollar to its lowest levels since 2008

  • Gold cracks $1,500 an ounce and is trading near 6-year highs

  • Global bond yields have dipped to 120-year lows

  • The VIX, the market’s fear index, got up as high as 24.79 on Monday, but managed to close below 20 on Friday, settling at 17.97. 

 


Can we expect more volatility ahead going into next week? 


What’s going on with commodities like gold and silver, are they a better place to be in than stocks moving forward? 


And what about the upcoming catalysts for the week, what should you be looking out for? 


I answer those questions and a whole lot more in the Jump.

More Volatility Ahead?

 

Well, U.S. stocks ended one of its most volatile weeks… and actually finished only slightly lower… which was remarkable, considering that major market indices were down ~3% on Monday, as well as the ongoing trade war concerns heading into the weekend.

President Trump stated yesterday, “We are not going to be doing business with Huawei… And I really made the decision. It’s much simpler not doing any business with Huawei. … That doesn’t mean we won’t agree to something if and when we make a trade deal.”

Not only that, the POTUS further escalated trade tensions by stating the U.S. is not ready to make a deal with China.

Keep in mind, the POTUS made its decision on Huawei after China halted purchases of U.S. agricultural products, as well as allowed its currency to drop below a key level against the dollar for the first time since 2008.

It’s quite clear that there are still ongoing trade tensions, and this volatility might not be over. With that being said, there are some key levels to watch in the SPDR S&P 500 ETF (SPY).

 

 

On the daily chart, $290 and $282 are levels to keep an eye on, as well as the 200-day simple moving average at $277.

 

 

On the hourly chart, we’ve seen a bullish crossover, and SPY is above $290… but has some resistance at $297 at the 200-hourly simple moving average. For now, I’m going to remain patient before I make any moves in SPY, or other market-tracking exchange-traded funds (ETFs) like QQQ or IWM.

 

Bond Yields Getting Crushed

 

Not only have stocks been volatile, but bond yields have been getting crushed, which is sending other asset classes soaring.

Why?

Well, global bond yields have dropped to a 120-year low, according to Bank of America  Merrill Lynch.

For example, we’ve seen the U.S. 10 Year Treasury Yield drop below 2% for the first time since 2017.

 

 

Not only that, the 30-Year Treasury Yield has been collapsing, and approaching the 2% very quickly.

When we see bond yields drop like this, it actually affects assets like gold and silver.

Gold prices broke above $1,500 for the first time in 6 years due to the political tensions, fears of a global economic slowdown, as well as the fall in yields.

 

 

Not only that, we’re seeing silver prices finally started to move higher last week, reaching levels it hasn’t seen in 18 months.

 

 

With that being said, I’m going to keep an eye on yields, bond ETFs like TLT and IEF, as well as gold- and silver-related stocks or ETFs… and of course the VIX.

There are a number of economic indicators next week, and they could give us clues as to where interest rates are headed… which can uncover multiple opportunities for us to trade.

 

Economic Calendar

Monday, August 12

  • 8:30 AM EST                   Monthly Budget Statement for July

Tuesday August 13

  • 6:00 AM EST                   NFIB Small Business Optimism
  • 7:45 AM EST                   ICSC Weekly Retail Sales
  • 8:30 AM EST                   Consumer Price Index (CPI)
  • 8:55 AM EST                   Johnson/Redbook Weekly Sales
  • 4:30 PM EST                   API Weekly Inventory Data

Wednesday August 14

  • 7:00 AM EST                   MBA Mortgage Applications Data
  • 8:30 AM EST                   Import Prices

Thursday August 15

  • 8:30 AM EST                   Weekly Jobless Claims
  • 8:30 AM EST                   Continuing Claims
  • 8:30 AM EST                   Empire Manufacturing
  • 8:30 AM EST                   Nonfarm Productivity
  • 8:30 AM EST                   Unit Labor Costs
  • 8:30 AM EST                   Retail Sales
  • 9:15 AM EST                   Industrial Production
  • 9:15 AM EST                   Capacity Utilization
  • 10:00 AM EST                 NAHB Housing Market Index
  • 10:00 AM EST                 Business Inventories
  • 10:30 AM EST                 Weekly DOE Inventory Data
  • 10:30 AM EST                 Weekly EIA Natural Gas Inventory Data
  • 4:00 PM EST                   Net Long-term TIC Flows

Friday August 16

  • 8:30 AM EST                   Housing Starts
  • 8:30 AM EST                   Building Permits
  • 10:00 AM EST                 University of Michigan Sentiment
  • 1:00 PM EST                   Baker Hughes Weekly Rig Count

 

We’ve still got a lot of companies reporting earnings as well.

Not only do traders have to figure out what’s going on with politics and macroeconomics, they’ve also got to analyze earnings right now. Next week, we’ve got a lot of large-caps reporting, and I’ll be keeping an eye on some of these to try to uncover some opportunities.

 

SYMBOL

EARNINGS DATE

CLOSE PRICE

IMPLIED MOVE

SYY

Aug. 12, 2019 BO

$69.99

4.46%

TSG

Aug. 12, 2019 BO

$15.98

10.26%

GOLD

Aug. 12, 2019 BO

$17.06

6.39%

EC

Aug. 12, 2019 AC

$16.69

6.99%

PAM

Aug. 12, 2019 AC

$35.12

10.87%

TEO

Aug. 12, 2019 AC

$15.70

5.85%

TME

Aug. 12, 2019 AC

$14.45

9.86%

JD

Aug. 13, 2019 BO

$27.10

8.02%

AAP

Aug. 13, 2019 BO

$144.33

7.96%

GDS

Aug. 13, 2019 BO

$38.42

8.32%

IAA

Aug. 13, 2019 BO

$45.01

8.30%

PSN

Aug. 13, 2019 BO

$37.14

7.24%

CVET

Aug. 13, 2019 BO

$23.82

13.14%

ELAN

Aug. 13, 2019 BO

$30.65

7.50%

IIVI

Aug. 13, 2019 BO

$38.07

9.59%

GO

Aug. 13, 2019 AC

$37.84

10.50%

YY

Aug. 13, 2019 AC

$52.12

9.63%

CDK

Aug. 13, 2019 AC

$48.66

5.53%

CPL

Aug. 13, 2019 AC

$17.11

2.89%

LTM

Aug. 13, 2019 AC

$9.80

8.06%

ADPT

Aug. 13, 2019 AC

$41.63

11.54%

BILI

Aug. 13, 2019 AC

$13.91

8.60%

HUYA

Aug. 13, 2019 AC

$20.39

12.62%

MYGN

Aug. 13, 2019 AC

$45.48

11.23%

TLRY

Aug. 13, 2019 AC

$42.57

11.73%

M

Aug. 14, 2019 BO

$19.43

9.55%

LK

Aug. 14, 2019 BO

$25.94

16.18%

AIT

Aug. 14, 2019 BO

$55.34

6.24%

ERJ

Aug. 14, 2019 BO

$19.83

4.90%

GOOS

Aug. 14, 2019 BO

$43.73

14.18%

PFGC

Aug. 14, 2019 BO

$43.86

6.30%

A

Aug. 14, 2019 AC

$68.64

5.71%

CGC

Aug. 14, 2019 AC

$32.90

9.65%

CHU

Aug. 14, 2019 AC

$9.27

3.24%

CIG

Aug. 14, 2019 AC

$3.66

28.77%

ELP

Aug. 14, 2019 AC

$13.13

7.63%

SBS

Aug. 14, 2019 AC

$14.51

6.98%

UGP

Aug. 14, 2019 AC

$4.91

4.65%

AABA

Aug. 14, 2019 AC

$70.02

0.40%

CACI

Aug. 14, 2019 AC

$211.23

5.90%

CSCO

Aug. 14, 2019 AC

$52.43

5.21%

NTAP

Aug. 14, 2019 AC

$46.58

6.49%

PRSP

Aug. 14, 2019 AC

$22.34

6.38%

STNE

Aug. 14, 2019 AC

$36.07

8.98%

VIPS

Aug. 14, 2019 AC

$6.49

12.30%

WUBA

Aug. 14, 2019 AC

$52.34

7.69%

AEG

Aug. 15, 2019 BO

$4.25

15.01%

GFI

Aug. 15, 2019 BO

$6.11

7.20%

MSG

Aug. 15, 2019 BO

$294.69

2.87%

NIO

Aug. 15, 2019 BO

$3.13

9.46%

TPR

Aug. 15, 2019 BO

$27.39

9.20%

WMT

Aug. 15, 2019 BO

$107.28

4.40%

BABA

Aug. 15, 2019 BO

$159.12

5.76%

CZZ

Aug. 15, 2019 AC

$14.23

9.59%

AMAT

Aug. 15, 2019 AC

$47.15

5.85%

GLOB

Aug. 15, 2019 AC

$107.35

9.14%

NVDA

Aug. 15, 2019 AC

$154.18

8.09%

VIAV

Aug. 15, 2019 AC

$14.20

7.78%

DE

Aug. 16, 2019 BO

$154.84

5.84%

QD

Aug. 16, 2019 BO

$8.92

12.89%

 

I think it could be another volatile week for the markets bumpy… and it can be very easy to get chopped up in all the back and forth price action.

A Historic Sentiment Shift

I always love watching how sentiment shift to pessimism when the market drops and optimism when the market rallies.

 

I always like to be doing the opposite.

 

 

A Historic Sentiment Shift

Irrational pessimism

The survey of individual investors from AAII can be noisy from week to week, with sometimes drastic changes. Even so, it’s rare to see them change as much as they did this week, with one of the largest drops in optimism in history.

Sentiment became so low, during a generally up trending market, that it has only preceded gains in the past. The one-week drop of more than 30% in the Bull Ratio is extreme for any kind of market environment, and again led to only gains over the medium- to long-term.

Island time

Traders panicked on Monday morning, forcing the futures well below Friday’s close by the time regular trading hours opened. After chopping around for a couple sessions, they did the opposite on Thursday, with an unfilled gap up. That left an island reversal in S&P futures, which has been a reliable sign of capitulation.

In an age of dominant passive investing high-frequency trading, price patterns may not be as reliable as they have been in past decades. But it’s at least worth considering that only one precedent led to a loss over the next 6 months.

Taking no chances

According to Lipper, investors yanked more than $25 billion from equity funds this week, the 2nd-most in 17 years. According to the Backtest Engine, any week with an outflow more than $20 billion led to gains in the S&P 500 every time over the next 6 months (and only one exception 2 and 8 weeks later).

No letup

The MSCI Emerging Markets index suffered 10 straight down days, culminating in its lowest level in more than 6 months. That’s only happened twice before in 30 years, in September 1990 and August 1998. Both led to more losses in the shorter-term, but a year later the index was higher by more than 35% both times.

 

 

Brian Sly

SPX/MKT BUY ALERT @ 2925- 8.9.19

As highlighted earlier- the MKT trading above 2924 indicates a continuation of this week’s counter-trend rally from the 2830-40-ish lows-

 

Look for a move to 2950-ish- , perhaps even higher-

 

 

 

Adam Lorraine-

Predictive Technology Group Announces Launch of PGxPLUS+™ Pharmacogenomic Test and Reaches Clinical Study Enrollment Milestone

Enrollment reaches 350 patients for IRB-approved study focused on chronic pain

SALT LAKE CITY, Aug. 09, 2019 (GLOBE NEWSWIRE) — Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent clinical intervention through precision therapies, announces that its wholly owned subsidiary Predictive Laboratories, Inc. has commercially launched PGxPLUS+, a pharmacogenomic test panel being marketed to pain clinics for patients with chronic pain.  PGxPLUS+ evaluates genetic factors that play a major role in an individual’s response to medications.  In parallel, Predictive Laboratories has reached a milestone of enrolling 350 patients with chronic pain into an Investigational Review Board-approved clinical study aimed at providing additional insight into the mechanisms of chronic pain and responses to pain therapies.

Predictive Technology Group is tackling chronic pain and the opioid crisis on multiple fronts. Predictive has already developed and in-licensed important prognostic DNA tests and novel treatments for osteoarthritis, lumbar disc disease, endometriosis, and other conditions causing chronic pain.  In 2016, the Institute of Medicine estimated that up to one-third of the U.S. population lives with ongoing pain.  Chronic pain is often triggered by one of these common conditions, and over time can develop into a chronic pain syndrome, which is a disease itself.

The PGxPLUS+ panel is one of the most comprehensive pharmacogenetic tests available on the market.  Predictive’s test evaluates 112 genetic variants across 38 genes that affect the metabolism of over 150 common medications, including pain medications.  More than 90% of the population has one or more gene variants that affect the efficacy or safety of prescription drugs.  Variation in drug metabolism is largely determined by an individual’s genetic profile, blood levels of a drug may vary up to 1,000-fold in similar patients taking identical doses of the same drug.  Pharmacogenomics is the study of the role of our genome in drug responses.

Dr. Bryt Christensen, M.D., a pain specialist, reports, “The PGxPLUS+ pharmacogenetic test has been very helpful in my day-to-day practice.  The results give insights into why some patients are not responding to medications as expected.  With the help of these test results, I have been able to start or switch medications for patients more successfully.  The PGxPLUS+ test helps me avoid prescribing medications that a patient won’t metabolize well, leading to better and more personalized patient care.” 

One-third of patients taking long-term opioid therapy for non-cancer chronic pain either find their medication to be ineffective or they do not tolerate the side effects of the treatment. In the clinical study, Predictive is testing patients who are taking high doses of opioids [≥50 morphine milligram equivalents (MME)/day] for genetic variants responsible for their underlying disease, their metabolism of opioids, their intrinsic pain thresholds, and any genetic predisposition to opioid addiction.  Predictive plans to develop more comprehensive treatment guidelines for pain based on predictive genetic markers. 

“The ability to effectively treat individuals in pain represents a significant market opportunity and of even greater importance it serves an obligation of society to alleviate the current pain and suffering of an individual in a safer and more effective manner,” said Bradley Robinson, CEO of Predictive Technology Group.  “Our Company is both identifying the most effective ways to treat pain at a personalized level and working to understand the underlying cause of diseases like osteoarthritis, lumbar disc disease and endometriosis to treat or prevent the root cause of the pain.  We are pleased to add the PGxPLUS+ test to our portfolio of regenerative medicine and diagnostic products focused on treating chronic pain diseases.”

About Predictive Technology Group, Inc.
Predictive Technology Group aims to revolutionize patient care through predictive data analytics, novel gene-based diagnostics and companion therapeutics through its subsidiaries Predictive Therapeutics, Predictive Biotech, and Predictive Laboratories. These subsidiaries are focused on endometriosis, scoliosis, degenerative disc disease, and human cell and tissue products. The subsidiaries use genetic and other information as cornerstones in the development of new diagnostics that assess a person’s risk of illness and therapeutic products designed to identify, prevent and treat diseases more effectively. Additional information is available at Predtechgroup.com, Predrx.com, Predictivebiotech.com, and Predictivelabs.com.

Forward-Looking Statements
To the extent any statements made in this release contain information that is not historical, these statements are essentially forward-looking and are subject to risks and uncertainties, including the difficulty of predicting FDA approvals, acceptance and demand for human cell and tissue products and other pharmaceutical products, the impact of competitive products and pricing, new product development and launch, reliance on key strategic alliances, availability of raw materials, availability of additional intellectual property rights, availability of future financing sources, the regulatory environment, and other risks the Company may identify from time to time in the future.

Contacts:
For more information, visit www.predtechgroup.com or contact Investor Relations:

Investor Contact
LHA Investor Relations
Jody Cain jcain@lhai.com 
Kevin Mc Cabe kmccabe@lhai.com 
310-691-7100

Most Anticipated Releases for the Week Beginning August 12, 2019

Overview calendar of the most anticipated earnings releases for the coming week

Are You Tired Of Spending YOUR Time Searching For New Stock Picks?

Save hours of research time with GorillaTrades! Each of GorillaTrades’ recommendations are clearly explained with the EXACT parameters needed to execute each trade. GorillaTrades tells you when to BUY and when to SELL. So, there is no more wondering if you got in or out too soon, and there is absolutely no guesswork! 

Try the GorillaTrades system absolutely FREE for the next 30 days, there is NO CREDIT CARD REQUIRED to sign up!

Click HERE For Instant Access To Explosive Stock & Options Picks





 

NVIDIA Corp. $154.18

NVIDIA Corp. (NVDA) is confirmed to report earnings at approximately 4:20 PM ET on Thursday, August 15, 2019. The consensus earnings estimate is $1.14 per share on revenue of $2.55 billion and the Earnings Whisper ® number is $1.18 per share. Investor sentiment going into the company’s earnings release has 68% expecting an earnings beat The company’s guidance was for earnings of $1.08 to $1.22 per share. Consensus estimates are for earnings to decline year-over-year by 35.59% with revenue decreasing by 18.35%. Short interest has decreased by 16.7% since the company’s last earnings release while the stock has drifted lower by 2.7% from its open following the earnings release to be 5.3% below its 200 day moving average of $162.75. Overall earnings estimates have been revised lower since the company’s last earnings release. On Friday, August 9, 2019 there was some notable buying of 7,738 contracts of the $155.00 call expiring on Friday, August 16, 2019. Option traders are pricing in a 8.5% move on earnings and the stock has averaged a 6.1% move in recent quarters.

Earnings Whispers Chart for NVDA

Alibaba Group Holding Ltd. $159.12

Alibaba Group Holding Ltd. (BABA) is confirmed to report earnings at approximately 7:00 AM ET on Thursday, August 15, 2019. The consensus earnings estimate is $1.51 per share on revenue of $16.53 billion and the Earnings Whisper ® number is $1.49 per share. Investor sentiment going into the company’s earnings release has 77% expecting an earnings beat. Consensus estimates are for year-over-year earnings growth of 42.45% with revenue increasing by 35.17%. Short interest has decreased by 49.9% since the company’s last earnings release while the stock has drifted lower by 10.1% from its open following the earnings release to be 3.1% below its 200 day moving average of $164.27. Overall earnings estimates have been revised lower since the company’s last earnings release. On Monday, August 5, 2019 there was some notable buying of 26,641 contracts of the $155.00 call expiring on Friday, January 17, 2020. Option traders are pricing in a 5.9% move on earnings and the stock has averaged a 3.8% move in recent quarters.

Walmart Inc. $107.28

Walmart Inc. (WMT) is confirmed to report earnings at approximately 7:00 AM ET on Thursday, August 15, 2019. The consensus earnings estimate is $1.21 per share on revenue of $130.49 billion and the Earnings Whisper ® number is $1.25 per share. Investor sentiment going into the company’s earnings release has 77% expecting an earnings beat. Consensus estimates are for earnings to decline year-over-year by 6.20% with revenue increasing by 1.92%. Short interest has increased by 4.8% since the company’s last earnings release while the stock has drifted higher by 4.3% from its open following the earnings release to be 6.5% above its 200 day moving average of $100.74. Overall earnings estimates have been revised higher since the company’s last earnings release. On Wednesday, August 7, 2019 there was some notable buying of 7,845 contracts of the $65.00 put expiring on Friday, October 18, 2019. Option traders are pricing in a 4.4% move on earnings and the stock has averaged a 4.5% move in recent quarters.

Cisco Systems, Inc. $52.43

Cisco Systems, Inc. (CSCO) is confirmed to report earnings at approximately 4:05 PM ET on Wednesday, August 14, 2019. The consensus earnings estimate is $0.82 per share on revenue of $13.39 billion and the Earnings Whisper ® number is $0.84 per share. Investor sentiment going into the company’s earnings release has 77% expecting an earnings beat The company’s guidance was for earnings of $0.80 to $0.82 per share. Consensus estimates are for year-over-year earnings growth of 15.49% with revenue increasing by 4.25%. Short interest has increased by 0.1% since the company’s last earnings release while the stock has drifted lower by 3.4% from its open following the earnings release to be 3.2% above its 200 day moving average of $50.81. Overall earnings estimates have been revised higher since the company’s last earnings release. On Monday, August 5, 2019 there was some notable buying of 15,504 contracts of the $50.00 put expiring on Friday, September 20, 2019. Option traders are pricing in a 5.4% move on earnings and the stock has averaged a 4.3% move in recent quarters.

JD.com, Inc. $27.10

JD.com, Inc. (JD) is confirmed to report earnings at approximately 6:50 AM ET on Tuesday, August 13, 2019. The consensus earnings estimate is $0.07 per share on revenue of $21.72 billion and the Earnings Whisper ® number is $0.08 per share. Investor sentiment going into the company’s earnings release has 75% expecting an earnings beat. Consensus estimates are for year-over-year earnings growth of 163.64% with revenue increasing by 17.53%. Short interest has decreased by 10.0% since the company’s last earnings release while the stock has drifted lower by 10.4% from its open following the earnings release to be 3.5% above its 200 day moving average of $26.19. Overall earnings estimates have been revised higher since the company’s last earnings release. On Monday, July 29, 2019 there was some notable buying of 35,248 contracts of the $31.00 put expiring on Friday, September 20, 2019. Option traders are pricing in a 8.5% move on earnings and the stock has averaged a 4.8% move in recent quarters.

Canopy Growth Corporation $32.90

Canopy Growth Corporation (CGC) is confirmed to report earnings at approximately 7:50 PM ET on Wednesday, August 14, 2019. The consensus estimate is for a loss of $0.28 per share on revenue of $85.97 million and the Earnings Whisper ® number is ($0.37) per share. Investor sentiment going into the company’s earnings release has 47% expecting an earnings beat. Consensus estimates are for year-over-year earnings growth of 9.68% with revenue increasing by 328.03%. The stock has drifted lower by 19.5% from its open following the earnings release to be 18.1% below its 200 day moving average of $40.17. Overall earnings estimates have been revised lower since the company’s last earnings release. On Monday, July 29, 2019 there was some notable buying of 2,221 contracts of the $37.50 call expiring on Friday, October 18, 2019. Option traders are pricing in a 9.5% move on earnings and the stock has averaged a 12.7% move in recent quarters.

Barrick Gold Corporation $18.14

Barrick Gold Corporation (GOLD) is confirmed to report earnings at approximately 7:00 AM ET on Monday, August 12, 2019. The consensus earnings estimate is $0.10 per share on revenue of $2.09 billion and the Earnings Whisper ® number is $0.11 per share. Investor sentiment going into the company’s earnings release has 70% expecting an earnings beat. Consensus estimates are for year-over-year earnings growth of 42.86% with revenue increasing by 22.08%. Short interest has increased by 29.8% since the company’s last earnings release while the stock has drifted higher by 41.7% from its open following the earnings release to be 32.8% above its 200 day moving average of $13.66. Overall earnings estimates have been revised higher since the company’s last earnings release. On Friday, July 26, 2019 there was some notable buying of 12,692 contracts of the $17.00 call and 12,625 contracts of the $17.00 put expiring on Friday, September 20, 2019. Option traders are pricing in a 5.7% move on earnings and the stock has averaged a 3.6% move in recent quarters.

SYSCO Corp. $69.99

SYSCO Corp. (SYY) is confirmed to report earnings at approximately 8:00 AM ET on Monday, August 12, 2019. The consensus earnings estimate is $1.07 per share on revenue of $15.56 billion and the Earnings Whisper ® number is $1.08 per share. Investor sentiment going into the company’s earnings release has 59% expecting an earnings beat. Consensus estimates are for year-over-year earnings growth of 13.83% with revenue increasing by 1.59%. Short interest has decreased by 25.8% since the company’s last earnings release while the stock has drifted lower by 1.4% from its open following the earnings release to be 3.0% above its 200 day moving average of $67.95. Overall earnings estimates have been revised higher since the company’s last earnings release. On Tuesday, August 6, 2019 there was some notable buying of 2,515 contracts of the $68.00 put expiring on Friday, August 16, 2019. Option traders are pricing in a 4.9% move on earnings and the stock has averaged a 5.3% move in recent quarters.

Applied Materials, Inc. $47.15

Applied Materials, Inc. (AMAT) is confirmed to report earnings at approximately 4:00 PM ET on Thursday, August 15, 2019. The consensus earnings estimate is $0.70 per share on revenue of $3.53 billion and the Earnings Whisper ® number is $0.72 per share. Investor sentiment going into the company’s earnings release has 86% expecting an earnings beat The company’s guidance was for earnings of $0.67 to $0.75 per share. Consensus estimates are for earnings to decline year-over-year by 41.67% with revenue decreasing by 20.99%. Short interest has increased by 20.2% since the company’s last earnings release while the stock has drifted higher by 8.8% from its open following the earnings release to be 19.3% above its 200 day moving average of $39.53. Overall earnings estimates have been revised higher since the company’s last earnings release. On Wednesday, July 24, 2019 there was some notable buying of 1,871 contracts of the $52.50 put expiring on Friday, September 20, 2019. Option traders are pricing in a 6.2% move on earnings and the stock has averaged a 4.6% move in recent quarters.

Tilray, Inc. $42.57

Tilray, Inc. (TLRY) is confirmed to report earnings at approximately 4:05 PM ET on Tuesday, August 13, 2019. The consensus estimate is for a loss of $0.23 per share on revenue of $40.23 million and the Earnings Whisper ® number is ($0.28) per share. Investor sentiment going into the company’s earnings release has 53% expecting an earnings beat. Consensus estimates are for earnings to decline year-over-year by 35.29% with revenue increasing by 312.87%. Short interest has increased by 52.0% since the company’s last earnings release while the stock has drifted lower by 14.9% from its open following the earnings release to be 36.7% below its 200 day moving average of $67.27. Overall earnings estimates have been revised lower since the company’s last earnings release. On Wednesday, August 7, 2019 there was some notable buying of 2,066 contracts of the $45.00 call expiring on Friday, March 20, 2020. Option traders are pricing in a 11.9% move on earnings and the stock has averaged a 8.2% move in recent quarters.

WEYL

CEO of Weyland Tech, Brent Suen, Discusses the Opportunity in Southeast Asia on the Fintech Wave

Thursday, August 1, 2019 12:00 PM

NEW YORK, NY / ACCESSWIRE / August 1, 2019 / The global payment processing solutions market is expected to grow from USD 39.3 billion in 2019 to USD 64.5 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 10.4% during the forecast period.

Major growth factors for the market include increasing worldwide initiatives for the promotion of digital and online payments, high proliferation of smartphones, focus on improving customer experience, and customers’ demand for immediacy of payments and settlements. These factors are expected to drive the global payment processing solutions market. However, the lack of a global standard for international transactions may limit market growth.

An eWallet is a way of storing payment methods, such as debit and credit cards, electronically so that individuals and businesses can send and receive payments through a mobile device, whether that is a tablet, smartwatch, or smartphone. Typically, an eWallet will be provided through an established payment processing model.

The eWallet market has been expanding rapidly, offering the benefits of mobile-based payments to consumers and businesses globally. However, the growing competition has already made it challenging for new entrants into space.

Brent Suen, CEO of Weyland Tech, Inc. (www.weyland-tech.com) recently shared tips and insights into the future of FinTech in Southeast Asia:

Factors that can lead your eWallet toward success

Offer an integrated solution

Your eWallet app is considered a solution for making a seamless, swift, and secure mobile transaction, but it can be so much more than that. It helps to develop partnerships with businesses already serving the market segment that you are looking at, and integrate the services and features that create more value for your users. You have to give them reasons to not only use your app but to stay in it.

Take care of comfort and convenience

Customers want an eWallet app that can make their life easier. The whole premise of an eWallet is to make users’ lives easier. Even the simple act of pulling a credit or debit card out from a physical wallet can be an inconvenience. It’s critical that your eWallet app offers both comfort and convenience in a secure way.

Pay attention to features

User-friendly features give your eWallet a competitive edge. Even if you are working within some constraints, whether they are regulatory, cultural, or technological, there are certain consumer expectations regarding the capabilities and convenience of both mobile devices and payment experiences that can’t be ignored if you hope to succeed. The users’ experience needs to feel natural and intuitive or they will return to traditional payment methods available to them. Users tend to appreciate the features they don’t even know exist the most.

Customer Service is paramount

Although eWallets are generally free, and the developer or publisher receives a percentage from transactions, either from the user or shop, many US consumers have a low tolerance for customer service that isn’t responsive or immediate. This cost center will make profitability as an eWallet provider a little longer roadmap. Many eWallet companies seek market share as opposed to profits and should they be properly funded by investors, have stronger staying power than those not well funded. Therefore, customer service is even more important to prevent customer ‘churn.’

Summing Up

In today’s mCommerce-driven age, individuals prefer mobile app-driven payment for all types of transactions. In the coming days, we can expect that the number of eWallet apps will rise. From paying bills to shopping, these apps are ready to perform multiple transactions in a secure and user-friendly way. Though the retail and e-commerce sector remains the biggest beneficiary of the eWallet app, every B2B and B2C business can leverage its benefits.

Media Contact Information

Shazir Mucklai
Email: shazir@imperium-pr.com

SOURCE: Weyland Tech